2,5-diphenyl-1,3,4-oxadiazole;2-(4-methylphenyl)-5-phenyl-1,3,4-oxadiazole;2-(1-phenylimidazol-2-yl)pyridine;bis(2-pyrazol-1-ylpyridine);2-pyridin-2-ylpyridine

C69H55N15O2 — CID 159886580

IUPAC2,5-diphenyl-1,3,4-oxadiazole;2-(4-methylphenyl)-5-phenyl-1,3,4-oxadiazole;2-(1-phenylimidazol-2-yl)pyridine;bis(2-pyrazol-1-ylpyridine);2-pyridin-2-ylpyridine
SMILESCc1ccc(-c2nnc(-c3ccccc3)o2)cc1.c1ccc(-c2ccccn2)nc1.c1ccc(-c2nnc(-c3ccccc3)o2)cc1.c1ccc(-n2cccn2)nc1.c1ccc(-n2cccn2)nc1.c1ccc(-n2ccnc2-c2ccccn2)cc1
InChIInChI=1S/C15H12N2O.C14H11N3.C14H10N2O.C10H8N2.2C8H7N3/c1-11-7-9-13(10-8-11)15-17-16-14(18-15)12-5-3-2-4-6-12;1-2-6-12(7-3-1)17-11-10-16-14(17)13-8-4-5-9-15-13;1-3-7-11(8-4-1)13-15-16-14(17-13)12-9-5-2-6-10-12;1-3-7-11-9(5-1)10-6-2-4-8-12-10;2*1-2-5-9-8(4-1)11-7-3-6-10-11/h2-10H,1H3;1-11H;1-10H;1-8H;2*1-7H
InChIKeyNUFDQOVXCQEVQG-UHFFFAOYSA-N
MW1126.30 g/mol
LogP14.73
Rot. Bonds9

About 2,5-diphenyl-1,3,4-oxadiazole;2-(4-methylphenyl)-5-phenyl-1,3,4-oxadiazole;2-(1-phenylimidazol-2-yl)pyridine;bis(2-pyrazol-1-ylpyridine);2-pyridin-2-ylpyridine

2,5-diphenyl-1,3,4-oxadiazole;2-(4-methylphenyl)-5-phenyl-1,3,4-oxadiazole;2-(1-phenylimidazol-2-yl)pyridine;bis(2-pyrazol-1-ylpyridine);2-pyridin-2-ylpyridine (PubChem CID 159886580) has the molecular formula C69H55N15O2 and a molecular weight of 1126.30 g/mol. Its IUPAC name is 2,5-diphenyl-1,3,4-oxadiazole;2-(4-methylphenyl)-5-phenyl-1,3,4-oxadiazole;2-(1-phenylimidazol-2-yl)pyridine;bis(2-pyrazol-1-ylpyridine);2-pyridin-2-ylpyridine.

Molecular Properties

Compound Name2,5-diphenyl-1,3,4-oxadiazole;2-(4-methylphenyl)-5-phenyl-1,3,4-oxadiazole;2-(1-phenylimidazol-2-yl)pyridine;bis(2-pyrazol-1-ylpyridine);2-pyridin-2-ylpyridine
PubChem CID159886580
Molecular FormulaC69H55N15O2
Molecular Weight1126.30 g/mol
Exact Mass1125.47
IUPAC Name2,5-diphenyl-1,3,4-oxadiazole;2-(4-methylphenyl)-5-phenyl-1,3,4-oxadiazole;2-(1-phenylimidazol-2-yl)pyridine;bis(2-pyrazol-1-ylpyridine);2-pyridin-2-ylpyridine
SMILESCc1ccc(-c2nnc(-c3ccccc3)o2)cc1.c1ccc(-c2ccccn2)nc1.c1ccc(-c2nnc(-c3ccccc3)o2)cc1.c1ccc(-n2cccn2)nc1.c1ccc(-n2cccn2)nc1.c1ccc(-n2ccnc2-c2ccccn2)cc1
InChIInChI=1S/C15H12N2O.C14H11N3.C14H10N2O.C10H8N2.2C8H7N3/c1-11-7-9-13(10-8-11)15-17-16-14(18-15)12-5-3-2-4-6-12;1-2-6-12(7-3-1)17-11-10-16-14(17)13-8-4-5-9-15-13;1-3-7-11(8-4-1)13-15-16-14(17-13)12-9-5-2-6-10-12;1-3-7-11-9(5-1)10-6-2-4-8-12-10;2*1-2-5-9-8(4-1)11-7-3-6-10-11/h2-10H,1H3;1-11H;1-10H;1-8H;2*1-7H
InChIKeyNUFDQOVXCQEVQG-UHFFFAOYSA-N
XLogP14.73
TPSA195.75 Ų
H-Bond Donors
H-Bond Acceptors17
Rotatable Bonds9
Heavy Atoms86
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001126.30
LogP ≤ 514.73
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1017

Analyze 2,5-diphenyl-1,3,4-oxadiazole;2-(4-methylphenyl)-5-phenyl-1,3,4-oxadiazole;2-(1-phenylimidazol-2-yl)pyridine;bis(2-pyrazol-1-ylpyridine);2-pyridin-2-ylpyridine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

N-[[3-[1-[2-(dimethylamino)ethyl]pyrazol-4-yl]imidazo[1,2-a]pyridin-6-yl]methyl]-N-methyl-5-[2-methyl-4-(1,3,5-trimethylpyrazol-4-yl)phenyl]-1,3,4-oxadiazol-2-amine
CID 164608966
N-methyl-N-[[3-(1-methylpiperidin-4-yl)imidazo[1,2-a]pyridin-6-yl]methyl]-5-[2-methyl-4-(1,3,5-trimethylpyrazol-4-yl)phenyl]-1,3,4-oxadiazol-2-amine
CID 164614228
N-methyl-N-[[3-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-6-yl]methyl]-5-[2-methyl-4-(1,3,5-trimethylpyrazol-4-yl)phenyl]-1,3,4-oxadiazol-2-amine
CID 164615038
US20240025892, Example 56
CID 170673726
methane;7-[[4-(5-methyl-1,3,4-oxadiazol-2-yl)phenyl]methyl]-2-(2-propan-2-ylphenyl)-5H-pyrrolo[2,3-d]pyrimidin-6-one;2-(2-propan-2-ylphenyl)-7-[(1R)-1-[4-(triazol-1-yl)phenyl]ethyl]-5H-pyrrolo[2,3-d]pyrimidin-6-one;2-(2-propan-2-ylphenyl)-7-[[4-[3-(trifluoromethyl)pyrazol-1-yl]phenyl]methyl]-5H-pyrrolo[2,3-d]pyrimidin-6-one
CID 157163912
methane;7-[[4-(5-methyl-1,3,4-oxadiazol-2-yl)phenyl]methyl]-2-(2-propan-2-ylphenyl)-5H-pyrrolo[2,3-d]pyrimidin-6-one;7-methyl-2-(2-propan-2-ylphenyl)-9-[(1R)-1-[4-(triazol-1-yl)phenyl]ethyl]purin-8-one;2-(2-propan-2-ylphenyl)-7-[[4-[3-(trifluoromethyl)pyrazol-1-yl]phenyl]methyl]-5H-pyrrolo[2,3-d]pyrimidin-6-one
CID 157371199
16-(4-Imidazo[1,2-a]pyrimidin-2-ylphenyl)-9-phenyl-4,9-diazahexacyclo[13.6.2.02,10.03,8.012,22.019,23]tricosa-1(22),2(10),3(8),4,6,11,13,15,17,19(23),20-undecaene;9-[3-methyl-5-(trifluoromethyl)phenyl]-16-phenyl-4,9-diazahexacyclo[13.6.2.02,10.03,8.012,22.019,23]tricosa-1(22),2(10),3(8),4,6,11,13,15,17,19(23),20-undecaene;2-phenyl-5-(9-phenyl-4,9-diazahexacyclo[13.6.2.02,10.03,8.012,22.019,23]tricosa-1(22),2(10),3(8),4,6,11,13,15,17,19(23),20-undecaen-16-yl)-1,3,4-oxadiazole
CID 158772688
1-[4,6-Bis(2-methylbenzimidazol-1-yl)-1,3,5-triazin-2-yl]-2-methylbenzimidazole;9-butan-2-ylcarbazole;2-(4-tert-butylphenyl)-5-(4-phenylphenyl)-1,3,4-oxadiazole;2-(2,4-difluorobenzene-6-id-1-yl)pyridine;bis(iridium);2-phenylpyridine;2-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyridine
CID 161135612
7-[[4-(5-methyl-1,3,4-oxadiazol-2-yl)phenyl]methyl]-2-(2-propan-2-ylphenyl)-5H-pyrrolo[2,3-d]pyrimidin-6-one;4-[[6-oxo-2-(2-propan-2-ylphenyl)-5H-pyrrolo[2,3-d]pyrimidin-7-yl]methyl]benzonitrile;2-(2-propan-2-ylphenyl)-7-[(1R)-1-[4-(triazol-1-yl)phenyl]ethyl]-5H-pyrrolo[2,3-d]pyrimidin-6-one;2-(2-propan-2-ylphenyl)-7-[[4-[3-(trifluoromethyl)pyrazol-1-yl]phenyl]methyl]-5H-pyrrolo[2,3-d]pyrimidin-6-one
CID 167617890
N-[[2-fluoro-4-[5-[4-[7-[3-fluoro-4-[[(5-methyl-[1,2,4]triazolo[4,3-a]pyridin-3-yl)amino]methyl]phenyl]-5-[[4-[7-[3-fluoro-4-[([1,2,4]triazolo[4,3-a]pyridin-3-ylamino)methyl]phenyl]-5-[[4-[7-[3-fluoro-4-[[[6-(trifluoromethyl)-[1,2,4]triazolo[4,3-a]pyridin-3-yl]amino]methyl]phenyl]-3H-imidazo[4,5-b]pyridin-2-yl]pyrazol-1-yl]methyl]-3H-imidazo[4,5-b]pyridin-2-yl]pyrazol-1-yl]methyl]-3H-imidazo[4,5-b]pyridin-2-yl]pyrazol-1-yl]-2-(1-methylpyrazol-4-yl)-3H-imidazo[4,5-b]pyridin-7-yl]phenyl]methyl]-5-phenyl-1,3,4-oxadiazol-2-amine
CID 174365372
3,3-Dimethyl-6-(4-methylimidazol-1-yl)-1-(2-methylpyrimidin-5-yl)indol-2-one;3,3-dimethyl-6-(5-methyl-1,3,4-oxadiazol-2-yl)-1-(2-methylpyrimidin-5-yl)indol-2-one
CID 118611607
2-Methyl-5-[5,5,21,21-tetramethyl-19-(5-methyl-1,3,4-oxadiazol-2-yl)-12-[5,5,21,21-tetramethyl-3,19-di(pyrimidin-2-yl)-1,17-diazanonacyclo[20.10.1.16,10.02,20.04,18.011,16.026,33.027,32.017,34]tetratriaconta-2(20),3,6,8,10(34),11,13,15,18,22,24,26(33),27,29,31-pentadecaen-12-yl]-1,17-diazanonacyclo[20.10.1.16,10.02,20.04,18.011,16.026,33.027,32.017,34]tetratriaconta-2(20),3,6,8,10(34),11,13,15,18,22,24,26(33),27,29,31-pentadecaen-3-yl]-1,3,4-oxadiazole
CID 146431270

Frequently Asked Questions

What is the IUPAC name of 2,5-diphenyl-1,3,4-oxadiazole;2-(4-methylphenyl)-5-phenyl-1,3,4-oxadiazole;2-(1-phenylimidazol-2-yl)pyridine;bis(2-pyrazol-1-ylpyridine);2-pyridin-2-ylpyridine?
The IUPAC name of 2,5-diphenyl-1,3,4-oxadiazole;2-(4-methylphenyl)-5-phenyl-1,3,4-oxadiazole;2-(1-phenylimidazol-2-yl)pyridine;bis(2-pyrazol-1-ylpyridine);2-pyridin-2-ylpyridine (CID 159886580) is 2,5-diphenyl-1,3,4-oxadiazole;2-(4-methylphenyl)-5-phenyl-1,3,4-oxadiazole;2-(1-phenylimidazol-2-yl)pyridine;bis(2-pyrazol-1-ylpyridine);2-pyridin-2-ylpyridine.
What is the SMILES notation for 2,5-diphenyl-1,3,4-oxadiazole;2-(4-methylphenyl)-5-phenyl-1,3,4-oxadiazole;2-(1-phenylimidazol-2-yl)pyridine;bis(2-pyrazol-1-ylpyridine);2-pyridin-2-ylpyridine?
The canonical SMILES for 2,5-diphenyl-1,3,4-oxadiazole;2-(4-methylphenyl)-5-phenyl-1,3,4-oxadiazole;2-(1-phenylimidazol-2-yl)pyridine;bis(2-pyrazol-1-ylpyridine);2-pyridin-2-ylpyridine is Cc1ccc(-c2nnc(-c3ccccc3)o2)cc1.c1ccc(-c2ccccn2)nc1.c1ccc(-c2nnc(-c3ccccc3)o2)cc1.c1ccc(-n2cccn2)nc1.c1ccc(-n2cccn2)nc1.c1ccc(-n2ccnc2-c2ccccn2)cc1.
What is the InChIKey of 2,5-diphenyl-1,3,4-oxadiazole;2-(4-methylphenyl)-5-phenyl-1,3,4-oxadiazole;2-(1-phenylimidazol-2-yl)pyridine;bis(2-pyrazol-1-ylpyridine);2-pyridin-2-ylpyridine?
The InChIKey is NUFDQOVXCQEVQG-UHFFFAOYSA-N. The full InChI is InChI=1S/C15H12N2O.C14H11N3.C14H10N2O.C10H8N2.2C8H7N3/c1-11-7-9-13(10-8-11)15-17-16-14(18-15)12-5-3-2-4-6-12;1-2-6-12(7-3-1)17-11-10-16-14(17)13-8-4-5-9-15-13;1-3-7-11(8-4-1)13-15-16-14(17-13)12-9-5-2-6-10-12;1-3-7-11-9(5-1)10-6-2-4-8-12-10;2*1-2-5-9-8(4-1)11-7-3-6-10-11/h2-10H,1H3;1-11H;1-10H;1-8H;2*1-7H.
What are the key properties of 2,5-diphenyl-1,3,4-oxadiazole;2-(4-methylphenyl)-5-phenyl-1,3,4-oxadiazole;2-(1-phenylimidazol-2-yl)pyridine;bis(2-pyrazol-1-ylpyridine);2-pyridin-2-ylpyridine?
2,5-diphenyl-1,3,4-oxadiazole;2-(4-methylphenyl)-5-phenyl-1,3,4-oxadiazole;2-(1-phenylimidazol-2-yl)pyridine;bis(2-pyrazol-1-ylpyridine);2-pyridin-2-ylpyridine has a molecular weight of 1126.30 g/mol, XLogP of 14.73, 9 rotatable bonds, 0 hydrogen bond donors, and 17 hydrogen bond acceptors.
Where does this data come from?
All data for 2,5-diphenyl-1,3,4-oxadiazole;2-(4-methylphenyl)-5-phenyl-1,3,4-oxadiazole;2-(1-phenylimidazol-2-yl)pyridine;bis(2-pyrazol-1-ylpyridine);2-pyridin-2-ylpyridine is sourced from PubChem (CID 159886580), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).